Saturday 17 October 2026 Export EBS’s income statement to Excel — free account

Emergent Biosolutions Inc.

EBS Healthcare Drug Manufacturers Specialty & Generic

Emergent Biosolutions Inc.’s revenue for fiscal 2025 (year ended December 2025) was $742.9 million, down 28.8% from fiscal 2024. In the quarter to June 2026, revenue grew 66.3%, EPS fell 1,486.4%, free cash flow fell 47.7% and total debt fell 12.9%, each against the same quarter a year earlier.

6.38 0.80 −11.14%

Follow EBS

Alert me

Market cap: $368.1M
P/E: 0.0×
Fwd P/E: −26.5×
Dividend yield: —
F-score: 6/9
Altman Z: 1.63
Beneish M: −3.56
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	13.01	6.26	+8 more quarters Free account
P/S ratio Full definition →	0.56	0.64	0.89	0.59
P/FCF ratio Full definition →	5.02	3.18	3.39	11.76
P/Operating CF Full definition →	7.71	(12.74)	8.51	(204.01)
P/B ratio Full definition →	1.27	0.82	1.27	0.81
Price to Tangible BV Full definition →	5.43	8.17	7.68	3.62
EV/Sales Full definition →	1.13	1.25	1.38	1.12
EV/EBITDA Full definition →	23.69	5.15	4.98	3.91
EV/Operating CF Full definition →	8.95	5.70	6.01	67.99
EV/FCF Full definition →	10.15	6.23	5.26	22.15
Quick Ratio Full definition →	2.69	1.90	2.22	2.92
Current Ratio Full definition →	5.42	4.29	5.01	5.76
Net Debt/EBITDA Full definition →	(4.43)	11.51	(201.67)	4.04
Debt/Assets Full definition →	52.10%	43.44%	43.39%	45.39%
Debt/Equity Full definition →	1.70	1.10	1.09	1.14
Asset Turnover Full definition →	0.61	0.49	0.55	0.54
Operating CF/Net income Full definition →	(0.31)	(4.97)	(1.42)	(0.04)
Capex/Depreciation Full definition →	(0.07)	(0.09)	(0.15)	(0.13)
Interest Coverage Full definition →	(12.51)	0.95	(1.90)	5.03
Research and Development Expense of Revenue Full definition →	3.93%	6.73%	8.14%	5.84%
Selling, General and Administrative Expense of Revenue Full definition →	19.04%	29.85%	34.36%	16.83%
Intangible Assets out of Total Assets Full definition →	0.23	0.36	0.33	0.31
Share Based Compensation of Revenue Full definition →	2.94%	1.22%	3.56%	2.08%
Graham Net Nets Full definition →	(0.25)	(0.37)	(0.20)	(0.20)
Graham Number Full definition →	0.00	0.00	14.45	18.64
Earnings Yield Full definition →	(41.05%)	(2.05%)	7.69%	15.99%
Free Cash Flow Yield Full definition →	19.91%	31.46%	29.49%	8.50%
Revenue per Share Full definition →	4.54	3.01	2.78	4.34
Operating CF per Share Full definition →	1.09	(0.65)	1.45	(0.04)
Capex per Share Full definition →	(0.04)	(0.05)	(0.07)	(0.06)
Free Cash Flow per Share Full definition →	1.05	(0.70)	1.38	(0.11)
Cash per Share Full definition →	2.73	3.11	3.91	4.68
Shareholders Equity per Share Full definition →	6.62	10.08	9.77	10.95
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	6.62	10.08	9.77	10.95
Free Cash Flow Full definition →	54.20	(36.20)	73.80	(5.70)
Working Capital Full definition →	543.20	488.90	530.30	650.40
Capital Expenditures Full definition →	(1.90)	(2.40)	(3.90)	(3.40)
Net Current Asset Value Full definition →	(109.40)	(159.70)	(133.50)	(91.60)
EV/EBIT Full definition →	0.00	13.90	10.24	7.46
Capex to Sales Full definition →	0.01	0.02	0.03	0.01
Price to Operating Income Full definition →	0.00	7.10	6.61	3.96
Other line items
Average Receivables Full definition →	134.90	162.65	119.35	135.40
Average Payables Full definition →	56.95	48.80	58.25	69.75
Average Inventory Full definition →	321.10	320.80	327.55	339.50
Average Assets Full definition →	1,266.95	1,373.25	1,354.15	1,469.40
Average Common Equity Full definition →	438.80	537.90	502.70	545.45

Fold the line items

Columns are period end dates

Stockrow Weekly